Results for tag: "Eluxadoline"

Eluxadoline is a drug used to treat gastrointestinal disorders such as irritable bowel syndrome with diarrhea (IBS-D). It is a mu-opioid receptor agonist and kappa-opioid receptor antagonist that works by reducing the activity of the gastrointestinal tract. It is available in both oral and intravenous forms. Eluxadoline is used to treat abdominal pain, bloating, and diarrhea associated with IBS-D. It is also used to reduce the frequency of episodes of abdominal pain and diarrhea in patients with IBS-D. Eluxadoline is a relatively new drug in the gastrointestinal market, having been approved by the US Food and Drug Administration (FDA) in 2016. It is currently the only FDA-approved drug for the treatment of IBS-D. Companies in the Eluxadoline market include Allergan, Ironwood Pharmaceuticals, and Synergy Pharmaceuticals. Allergan manufactures and markets the oral form of Eluxadoline, while Ironwood Pharmaceuticals manufactures and markets the intravenous form. Synergy Pharmaceuticals is a biopharmaceutical company that is developing a new formulation of Eluxadoline. Show Less Read more